The industry of stem cell therapy is experiencing rapid growth, attracting both significant investment and heightened public interest. This multifaceted financial landscape is shaped by a range of elements, including regulatory frameworks, development costs, and the evolving demands of the market. Deciphering this terrain is crucial for both invest

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These techniques involve small incisions and minimal tissue manipulation, resulting in quicker recovery times, r